Cytion293F-X Cells
690,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | Cytion293F-X refers to a suspension-adapted human embryonic kidney cell line equivalent to HEK293F cells, derived from the original HEK293 lineage. These cells originate from human embryonic kidney tissue and have been adapted for growth in serum-free, chemically defined media under suspension culture conditions. This adaptation enables high-density growth in shaker flasks or bioreactors, making them particularly suitable for large-scale protein expression. Like other HEK293 derivatives, 293F-X cells retain the adenoviral E1A/E1B genomic integration that supports robust transgene expression. Cytion293F-X cells are optimized for transient transfection workflows, especially for the production of recombinant proteins, monoclonal antibodies, and viral vectors. They exhibit high transfection efficiency using chemical methods such as polyethyleneimine (PEI) or lipid-based reagents, and are capable of producing substantial protein yields within short timeframes. Their suspension growth and scalability allow for efficient upscaling from small laboratory volumes to industrial bioprocessing systems, while maintaining consistent expression performance. In addition to protein production, Cytion293F-X cells are widely used in virology and gene delivery research, including the generation of adeno-associated virus (AAV) and lentiviral particles. They maintain key characteristics of HEK293-derived systems, including human-like post-translational modification machinery, which is critical for proper protein folding and glycosylation. However, as with other HEK293 variants, genomic heterogeneity and clonal variation may influence expression outcomes, and optimization of culture and transfection parameters is often required for specific applications. |
|---|---|
| Organisme | Human |
| Tissu | Kidney |
| Maladie | Normal human embryonic kidney (HEK293-derived; suspension-adapted; not tumorigenic in standard use) |
| Site métastatique | Not applicable (non-tumorigenic HEK293 derivative adapted for suspension culture) |
| Applications | Recombinant protein and antibody production; transient transfection host; AAV and lentiviral vector manufacturing; suspension bioreactor culture; scalable GMP-compatible expression systems; post-translational modification studies |
Caractéristiques
| Âge | Fetus |
|---|---|
| Genre | Female |
| Origine ethnique | Not applicable (immortalized embryonic kidney cell line) |
| Morphologie | Epithelial-like |
| Type de cellule | Epithelial cells (embryonic kidney) |
| Propriétés de croissance | Suspension |
Données réglementaires
| Référence | Cytion293F-X (Cytion catalog number 305927) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | Not assigned (Cytion293F-X is a proprietary suspension-adapted HEK293F derivative; parental HEK293 CVCL_0045) |
| Statut OGM | GMO-S1: This Cytion293F-X cell line contains SV40, enabling high transfection efficiency and robust growth in suspension culture. The modification is stably present in embryonic kidney cells. This classification applies only within Germany and may differ elsewhere. |
Données biomoléculaires
| Récepteurs exprimés | Vitronectin |
|---|---|
| Expression des protéines | CEA negative, p53 positive |
| Tumorigène | In nude mice |
| Virus | Transformed with adenovirus 5 DNA adenovirus 5 DNA |
Manipulation
| Milieu de culture | Expi293 Expression Medium |
|---|---|
| Réactif de dissociation | None |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Densité de semis | 0.3 to 1 x 106 cells/ml |
| Renouvellement des fluides | 2 times per week |
| Rétablissement après le dégel | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305927-200326 | Certificat d'analyse | 04. May. 2026 | 305927 |